Small-cell lung cancer spreads quickly. From 67%-75% of people who develop small cell lung cancerwill have spread the SCLC outside of the lung to other parts of the body at the time of initial diagnosis. Small-cell lung cancer responds well to chemotherapy (using medications to kill cancer...
Small cell lung cancer survival: a 5-year cohort at Aneurin Bevan University Health Boarddoi:10.1016/S0169-5002(20)30181-1P. EvansR. JohnR. PortherN. GomezA. IonescuLung Cancer
This cohort study evaluates trends in survival after immune checkpoint inhibitor therapy in patients with advanced non–small cell lung cancer by age.
Non-small-cell lung cancer Age Survival TreatmentThe present study was conducted to determine whether it is justifiable to adapt treatment to age in patients with non-small-cell lung cancer (NSCLC). All NSCLC patients treated at the Institut Jules Bordet who were 75 years old or over were ...
Non-small cell lung cancer (NSCLC) is uncommonly diagnosed in patients younger than 50 years of age. We analyzed the California Cancer Registry (CCR) to describe epidemiologic characteristics and outcomes in this patient subset and to identify factors prognostic for cause-specific survival (CSS). ...
Lung Cancer Volume 11, Supplement 1, June 1994, Pages 85Abstract Supportive careLong term survival in small cell lung cancer (SCLC) patients: A French prospective study : P. Jacoulet, A. Depierre, E. Quoix, D. Moro, E. Ranfaing, B. Lebeau, A. Rivière, B. Milleron, F. Capron, ...
Non-small cell lung cancer; postoperative follow-up; thoracic surgery; expert consensus DOI: 10.7507/1007-4848.202501057 Export PDF Favorites Scan Get Citation Shared Abstract Figures/Tables References Cited by Surgical treatment is one of the key approaches for non-small cell lung cancer (...
Distribution of Lung Cancer by Histologic Findings and Distribution of NSCLC by Stage, Age, and Year View LargeDownload NOS indicates not otherwise specified; NSCLC, non–small cell lung cancer; SEER-18, Surveillance, Epidemiology, and End Results; NPCR, National Program of Cancer Registries. A,...
Consolidation durvalumab improved survival across subgroups of patients with limited-stage small cell lung cancer based on factors associated with prior prophylactic cranial irradiation and concurrent chemoradiotherapy use. Among patients with prior PCI in the durvalumab and placebo arms, the median ...
Kaplan–Meier survival curves of CSS in patients with radiotherapy and non-radiotherapy groups with different treatment modalities. (A) with surgery, and (B) without surgery. Full size image Discussion Small Cell Lung Cancer (SCLC) is a high-grade neuroendocrine cancer characterized by its aggressiv...